Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 57
Filter
1.
PLoS One ; 18(8): e0290777, 2023.
Article in English | MEDLINE | ID: mdl-37651428

ABSTRACT

INTRODUCTION: Case-finding algorithms can be applied to administrative healthcare records to identify people with diseases, including people with HIV (PWH). When supplementing an existing registry of a low prevalence disease, near-perfect specificity helps minimize impacts of adding in algorithm-identified false positive cases. We evaluated the performance of algorithms applied to healthcare records to supplement an HIV registry in British Columbia (BC), Canada. METHODS: We applied algorithms based on HIV-related diagnostic codes to healthcare practitioner and hospitalization records. We evaluated 28 algorithms in a validation sub-sample of 7,124 persons with positive HIV tests (2,817 with a prior negative test) from the STOP HIV/AIDS data linkage-a linkage of healthcare, clinical, and HIV test records for PWH in BC, resembling a disease registry (1996-2020). Algorithms were primarily assessed based on their specificity-derived from this validation sub-sample-and their impact on the estimate of the total number of PWH in BC as of 2020. RESULTS: In the validation sub-sample, median age at positive HIV test was 37 years (Q1: 30, Q3: 46), 80.1% were men, and 48.9% resided in the Vancouver Coastal Health Authority. For all algorithms, specificity exceeded 97% and sensitivity ranged from 81% to 95%. To supplement the HIV registry, we selected an algorithm with 99.89% (95% CI: 99.76% - 100.00%) specificity and 82.21% (95% CI: 81.26% - 83.16%) sensitivity, requiring five HIV-related healthcare practitioner encounters or two HIV-related hospitalizations within a 12-month window, or one hospitalization with HIV as the most responsible diagnosis. Upon adding PWH identified by this highly-specific algorithm to the registry, 8,774 PWH were present in BC as of March 2020, of whom 333 (3.8%) were algorithm-identified. DISCUSSION: In the context of an existing low prevalence disease registry, the results of our validation study demonstrate the value of highly-specific case-finding algorithms applied to administrative healthcare records to enhance our ability to estimate the number of PWH living in BC.


Subject(s)
Acquired Immunodeficiency Syndrome , Male , Humans , Adult , Female , British Columbia/epidemiology , Prevalence , Algorithms , Dietary Supplements
2.
Can Vet J ; 64(5): 451-456, 2023 05.
Article in English | MEDLINE | ID: mdl-37138707

ABSTRACT

Objective: This cross-sectional study aimed to evaluate serum total protein (STP) concentrations in surplus calves in British Columbia and explore associated factors including calf breed, sex, hydration, month of sampling, and frequency of calf pickup. Animal: Neonatal dairy and dairy-beef crossbred calves recently purchased from dairy farms and transported to an assembly facility. Procedure: Calves included in this study (N = 1449) were assessed at an assembly facility from March to August 2021, and blood samples were collected to measure STP as an indicator of transfer of passive immunity (TPI). Associations between STP and calf characteristics (breed, sex, hydration), month of sampling, and how frequently calves were collected from the source dairy farms (daily versus twice weekly or less) were evaluated with a linear regression model including farm as a random effect. Results: Of the 1433 serum samples, 24% had STP concentrations that were "poor:" defined as < 5.1 g/dL, and the proportion with poor STP varied widely among farms. Dairy-beef crossbred calves and calves that were dehydrated had higher STP concentrations, whereas those sampled in July had lower STP. This study was limited to calves purchased by 1 calf buyer but represented a large number of calves from 12% of the dairy farms in British Columbia. Conclusion: Approximately 1/4 of surplus dairy calves had poor STP concentrations. Clinical relevance: Ensuring surplus dairy calves have successful TPI is an important opportunity to bolster their health and welfare.


Concentrations sériques des protéines totales chez les veaux laitiers excédentaires en Colombie-Britannique. Objectif: Cette étude transversale visait à évaluer les concentrations sériques des protéines totales (STP) chez les veaux excédentaires en Colombie-Britannique et à explorer les facteurs associés, notamment la race de veau, le sexe, l'hydratation, le mois d'échantillonnage et la fréquence de ramassage des veaux. Animal: Veaux nouveau-nés issus de croisements laitier et laitier-boeuf achetés récemment à des fermes laitières et transportés vers une installation commune. Procédure: Les veaux inclus dans cette étude (N = 1449) ont été évalués dans une installation commune de mars à août 2021, et des échantillons de sang ont été prélevés pour mesurer les STP comme indicateur du transfert de l'immunité passive (TPI). Les associations entre les STP et les caractéristiques des veaux (race, sexe, hydratation), le mois d'échantillonnage et la fréquence à laquelle les veaux ont été ramassés dans les fermes laitières d'origine (quotidiennement versus deux fois par semaine ou moins) ont été évaluées avec un modèle de régression linéaire incluant la ferme comme effet aléatoire. Résultats: Sur les 1433 échantillons de sérum, 24 % présentaient des concentrations de STP « médiocres ¼ définies comme < 5,1 g/dL, et la proportion avec des STP médiocres variait considérablement d'une ferme à l'autre. Les veaux issus de croisements lait-boeuf et les veaux déshydratés présentaient des concentrations de STP plus élevées, tandis que ceux échantillonnés en juillet présentaient des concentrations de STP plus faibles. Cette étude se limitait aux veaux achetés par un acheteur de veaux, mais représentait un grand nombre de veaux provenant de 12 % des fermes laitières de la Colombie-Britannique. Conclusion: Environ le quart des veaux laitiers excédentaires avaient de faibles concentrations de STP. Pertinence clinique: Veiller à ce que les veaux laitiers excédentaires aient un transfert d'immunité passive réussie est une occasion importante de renforcer leur santé et leur bien-être.(Traduit par Dr Serge Messier).


Subject(s)
Colostrum , Pregnancy , Female , Animals , Cattle , Animals, Newborn , Cross-Sectional Studies , British Columbia/epidemiology , Farms
3.
CMAJ ; 195(8): E292-E299, 2023 02 27.
Article in English | MEDLINE | ID: mdl-36849178

ABSTRACT

BACKGROUND: Anecdotal evidence suggests that the profile of midwifery clients in British Columbia has changed over the past 20 years and that midwives are increasingly caring for clients with moderate to high medical risk. We sought to compare perinatal outcomes with a registered midwife as the most responsible provider (MRP) versus outcomes among clients with physicians as their MRP across medical risk strata. METHODS: This retrospective cohort study (2008-2018) used data from the BC Perinatal Data Registry. We included all births that had a family physician, obstetrician or midwife listed as the MRP (n = 425 056) and stratified the analysis by pregnancy risk status (low, moderate or high) according to an adapted perinatal risk scoring system. We estimated differences in outcomes between MRP groups by calculating adjusted absolute and relative risks. RESULTS: The adjusted absolute and relative risks of adverse neonatal outcomes were consistently lower among those who chose midwifery care across medical risk strata, compared with clients who had a physician as MRP. Midwifery clients experienced higher rates of spontaneous vaginal births, vaginal births after cesarean delivery and breastfeeding initiation, and lower rates of cesarean deliveries and instrumental births, with no increase in adverse neonatal outcomes. We observed an increased risk of oxytocin induction among high-risk birthers with a midwife versus an obstetrician as MRP. INTERPRETATION: Our findings suggest that compared with other providers in BC, midwives provide safe primary care for clients with varied levels of medical risk. Future research might examine how different practice and remuneration models affect clinical outcomes, client and provider experiences, and costs to the health care system.


Subject(s)
Midwifery , Female , Pregnancy , Infant, Newborn , Humans , British Columbia/epidemiology , Retrospective Studies , Parturition , Physicians, Family
4.
Midwifery ; 113: 103437, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35908443

ABSTRACT

OBJECTIVE: To explore midwives' experiences working on the frontlines of the COVID-19 pandemic in British Columbia, Canada. DESIGN: Qualitative study involving three semi-structured focus groups and four in-depth interviews with midwives. SETTING: The COVID-19 pandemic in British Columbia, Canada from 2020-2021. PARTICIPANTS: 13 midwives working during the first year of the COVID-19 pandemic in British Columbia. FINDINGS: Qualitative analysis surfaced four key themes. First, midwives faced a substantial lack of support during the pandemic. Second, insufficient support was compounded by a lack of recognition. Third, participants felt a strong duty to continue providing high-quality care despite COVID-19 related restrictions and challenges. Lastly, lack of support, increased workloads, and moral distress exacerbated burnout among midwives and raised concerns around the sustainability of their profession. KEY CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: Lack of effective support for midwives during the initial months of the COVID-19 pandemic exacerbated staffing shortages that existed prior to the pandemic, creating detrimental gaps in essential care for pregnant people, especially with increasing demands for homebirths. Measures to support midwives should combat inequities in the healthcare system, mitigating the risks of disease exposure, burnout, and professional and financial impacts that may have long-lasting implications on the profession. Given the crucial role of midwives in women- and people-centred care and advocacy, protecting midwives and the communities they serve should be prioritized and integrated into pandemic preparedness and response planning to preserve women's health and rights around the world.


Subject(s)
COVID-19 , Midwifery , British Columbia/epidemiology , Female , Humans , Pandemics , Pregnancy , Qualitative Research
5.
BMC Pregnancy Childbirth ; 21(1): 271, 2021 Apr 01.
Article in English | MEDLINE | ID: mdl-33794806

ABSTRACT

BACKGROUND: Oral diseases are considered a silent epidemic including among pregnant women. Given the prevalence of oral conditions among pregnant women and the reported association with adverse pregnancy outcomes, there have been suggestions for the inclusion of preventive oral care in routine prenatal care. However, due to the different administrative and funding structure for oral health and prenatal care in Canada, progress towards this integration has been slow. Our study sought to qualitatively explore the views of pregnant women in British Columbia (BC) on the strategies for integrating preventive oral health care into prenatal care services. METHODS: A qualitative approach was utilized involving semi-structured interviews with fourteen (14) purposefully selected pregnant women in Vancouver and Surrey, BC. The interviews were audio-recorded and transcribed. The transcripts were analyzed using an inductive thematic approach. Study validity was ensured via memoing, field-notes, and member checking. RESULTS: Interviews ranged from 28 to 65 min producing over 140 pages of transcripts. Analysis resulted in three major themes: oral health experiences during pregnancy, perspectives on integration and integrated prenatal oral care, and strategies for addressing prenatal oral health care. A majority of participants were supportive of integrating preventive oral care in routine prenatal services, with referrals identified as a critical strategy. Oral health education was recognized as important before, during, and after pregnancy; oral health assessments should therefore be included in the prenatal care checklist. Limited funding was acknowledged as a barrier to oral health care access, which may explain why few participants visited their dentists during pregnancy. Interprofessional education surfaced as a bridge to provide prenatal oral health education. CONCLUSION: Pregnant women interviewed in this study support the inclusion of educational and preventive oral care during prenatal care, although their views differed on how such inclusion can be achieved in BC. They advocated the establishment of a referral system as an acceptable strategy for providing integrated prenatal oral health care.


Subject(s)
Delivery of Health Care, Integrated/organization & administration , Mouth Diseases/prevention & control , Pregnancy Complications/prevention & control , Prenatal Care/organization & administration , Preventive Health Services/organization & administration , Adult , British Columbia/epidemiology , Female , Health Education/organization & administration , Humans , Mouth Diseases/epidemiology , Oral Health , Pregnancy , Pregnancy Complications/epidemiology , Prevalence , Qualitative Research , Stakeholder Participation , Surveys and Questionnaires
6.
J Obstet Gynaecol Can ; 43(6): 740-745, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33677139

ABSTRACT

OBJECTIVE: There is limited evidence of the impact of cannabis legalization on the prevalence of cannabis use and use of other substances. The aim of this exploratory observational study was to compare rates of cannabis use, cigarette smoking, alcohol consumption, and the use of any street drugs during the preconception period and in pregnancy in two convenience samples of pregnant persons in British Columbia, Canada, before and after the legalization of cannabis. METHODS: Any pregnant person residing in British Columbia, aged >19 years, at any gestational age was eligible to participate. Pre- and post-legalization study participants were recruited between May and October 2018 and July 2019 and May 2020, respectively. Multivariate models were constructed to examine the effect of legalization on cigarette smoking and the use of cannabis, alcohol, and street drugs, adjusting for demographic, pre-pregnancy, and pregnancy confounders. RESULTS: From pre- to post-legalization, the prevalence of self-reported cannabis use during the preconception period increased significantly, from 11.74% (95% CI 9.19%-14.88%) to 19.38% (95% CI 15.45%-24.03%). Rates of cannabis use during pregnancy also increased from 3.64% (95% CI 2.32%-5.69%) before legalization to 4.62% (95% CI 2.82%-7.47%) after; however, this difference was not statistically significant. Adjusting for potential confounders, the post-legalization group had significantly higher odds of cannabis use during the preconception period (adjusted odds ratio 1.71; 95% CI 1.14-2.58) but not during pregnancy (adjusted odds ratio 1.66; 95% CI 0.75-3.65). Legalization was also not associated with significant changes in cigarette smoking, alcohol consumption, or the use of street drugs during the preconception period and pregnancy, after adjusting for potential confounders. CONCLUSION: The preliminary evidence presented in this study shows that the legalization of cannabis was associated with 71% higher odds of cannabis use during the preconception period. Studies examining the effects of cannabis use on perinatal outcomes, as well as public health interventions and educational programs related to cannabis use, should include the preconception period as an area of focus.


Subject(s)
Alcohol Drinking/epidemiology , Cannabis/adverse effects , Cigarette Smoking/epidemiology , Medical Marijuana/therapeutic use , Preconception Care , Prenatal Care , British Columbia/epidemiology , Female , Humans , Illicit Drugs , Perinatal Care , Pregnancy , Pregnant Women , Prevalence
7.
Birth ; 48(3): 301-308, 2021 09.
Article in English | MEDLINE | ID: mdl-33583048

ABSTRACT

BACKGROUND: The aim of this retrospective population-based cohort study was to determine whether the mode of delivery and maternal and neonatal outcomes differ between planned home VBAC (HBAC) and planned hospital VBAC. METHODS: All midwifery clients with at least one prior cesarean birth delivered between April 2000 and March 2017 (N = 4741; n = 4180 planned hospital VBAC, n = 561 planned HBAC) were included. Multivariate binomial logistic regression analyses were conducted to calculate the odds ratios adjusted for the potential covariates. The primary outcome was the mode of delivery, and the secondary outcomes were uterine rupture/dehiscence, postpartum hemorrhage, nonintact perineum, episiotomy, obstetric trauma, Apgar score <7 at 5 minutes, neonatal resuscitation requiring positive pressure ventilation, neonatal intensive care unit admission, and a composite outcome of severe neonatal mortality and morbidity and maternal mortality and morbidity. RESULTS: Planned HBAC was associated with a significant 39% decrease in the odds of having a cesarean birth (aOR 0.61, 95% CI 0.47-0.79) adjusting for the prepregnancy and pregnancy characteristics. Severe adverse outcomes were relatively rare in both settings; thus, our study did not have sufficient power to detect the true differences associated with the place of birth. CONCLUSIONS: Home births for those eligible for VBACs and attended by registered midwives within an integrated health system were associated with higher vaginal birth rates compared with planned hospital VBACs. Severe adverse outcomes were relatively rare in both settings.


Subject(s)
Home Childbirth , Vaginal Birth after Cesarean , British Columbia/epidemiology , Cohort Studies , Female , Hospitals , Humans , Infant, Newborn , Pregnancy , Resuscitation , Retrospective Studies
8.
Public Health Nutr ; 24(5): 1021-1033, 2021 04.
Article in English | MEDLINE | ID: mdl-32366338

ABSTRACT

OBJECTIVE: To further understandings of household food insecurity in First Nations communities in Canada and its relationship with obesity. DESIGN: Analysis of a cross-sectional dataset from the First Nations Food, Nutrition and Environment Study representative of First Nations communities south of the 60th parallel. Multivariate logistic regression was used to assess associations between food insecurity and sociodemographic factors, as well as the odds of obesity among food-insecure households adjusting for sociodemographic characteristics. SETTING: Western and Central Canada. PARTICIPANTS: First Nations peoples aged ≥19 years. RESULTS: Forty-six percent of First Nations households experienced food insecurity. Food insecurity was highest for respondents who received social assistance; had ≤10 years of education; were female; had children in the household; were 19-30 years old; resided in Alberta; and had no year-round road access into the community. Rates of obesity were highest for respondents residing in marginally food-insecure households (female 56·6 %; male 54·6 %). In gender-specific analyses, the odds of obesity were highest among marginally food-insecure households in comparison with food-secure households, for both female (OR 1·57) and male (OR 1·57) respondents, adjusting for sociodemographic variables. For males only, those in severely food-insecure (compared with food-secure) households had lower odds of obesity after adjusting for confounding (OR 0·56). CONCLUSIONS: The interrelated challenges of food insecurity and obesity in First Nations communities emphasise the need for Indigenous-led, culturally appropriate and food sovereign approaches to food security and nutrition in support of holistic wellness and prevention of chronic disease.


Subject(s)
Food Insecurity , Food Supply , Adult , Alberta/epidemiology , British Columbia/epidemiology , Child , Cross-Sectional Studies , Female , Humans , Male , Manitoba , Obesity/epidemiology , Ontario/epidemiology , Socioeconomic Factors , Young Adult
9.
Breast Cancer Res Treat ; 186(2): 519-525, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33146785

ABSTRACT

PURPOSE: In British Columbia (BC), there have been 2790 confirmed COVID-19 cases as of June 20, 2020. The aim of this project is to capture the effect of COVID-19 on the volume of surgery and adaptations to the surgical care of patients at a breast centre in BC. METHODS: All proven or suspected breast cancer cases treated with surgery between March 16, 2019 and April 30, 2019 and March 16, 2020 and April 30, 2020 through the Providence Breast Centre were included in this review. The date ranges in 2020 mark the early COVID-19 pandemic period in BC and the large shift in operating room access during this time. RESULTS: In 2019, 99 patients underwent surgery for proven breast cancer and 30 patients for suspected breast cancer. In 2020, 162 patients underwent surgery for breast cancer and 34 for suspected breast cancer. Wait times from core biopsy to surgery and surgery to oncology consultation were improved in 2020 with a reduction of core biopsy to surgery time from 58 to 28 days for patients seen during the pandemic. There was an increased use of regional anesthesia and same day discharge compared to 2019 with increases in regional anesthesia (41%-89%) and same day discharge (64%-86%) after adaptations to the pandemic were implemented. CONCLUSIONS: Changes such as improved access to telemedicine, timing for cancer surgeries, and safer anesthetic techniques in response to the pandemic will change breast cancer surgical care beyond the pandemic era. Centralization and team-based care is the way forward.


Subject(s)
Breast Neoplasms/surgery , COVID-19/epidemiology , Anesthesia, Local , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , British Columbia/epidemiology , COVID-19/prevention & control , Cancer Care Facilities , Female , Health Services Accessibility , Humans , Middle Aged , Patient Discharge , Retrospective Studies , SARS-CoV-2 , Telemedicine , Time-to-Treatment
10.
CMAJ Open ; 8(2): E319-E327, 2020.
Article in English | MEDLINE | ID: mdl-32371526

ABSTRACT

BACKGROUND: Incentive payments for chronic diseases in British Columbia were intended to support primary care physicians in providing more comprehensive care, but research shows that not all physicians bill incentives and not all eligible patients have them billed on their behalf. We investigated patient and physician characteristics associated with billing incentives for chronic diseases in BC. METHODS: We conducted a retrospective cohort analysis using linked administrative health data to examine community-based primary care physicians and patients with eligible chronic conditions in BC during 2010-2013. Descriptive analyses of patients and physicians compared 3 groups: no incentives in any of the 4 years, incentives in all 4 years, and incentives in any of the study years. We used hierarchical logistic regression models to identify the patient- and physician-level characteristics associated with billing incentives. RESULTS: Of 428 770 eligible patients, 142 475 (33.2%) had an incentive billed on their behalf in all 4 years, and 152 686 (35.6%) never did. Of 3936 physicians, 2625 (66.7%) billed at least 1 incentive in each of the 4 years, and 740 (18.8%) billed no incentives during the study period. The strongest predictors of having an incentive billed were the number of physician contacts a patient had (odds ratio [OR] for > 48 contacts 134.77, 95% confidence interval [CI] 112.27-161.78) and whether a physician had a large number of patients in his or her practice for whom incentives were billed (OR 42.38 [95% CI 34.55-52.00] for quartile 4 v. quartile 1). INTERPRETATION: The findings suggest that primary care physicians bill incentives for patients based on whom they see most often rather than using a population health management approach to their practice.


Subject(s)
Chronic Disease/epidemiology , Physicians, Primary Care , Primary Health Care , Reimbursement, Incentive , Adolescent , Adult , Aged , Aged, 80 and over , British Columbia/epidemiology , Female , Humans , Male , Middle Aged , Population Health Management , Practice Patterns, Physicians' , Quality of Health Care , Retrospective Studies , Young Adult
11.
J Alzheimers Dis ; 76(1): 179-193, 2020.
Article in English | MEDLINE | ID: mdl-32444553

ABSTRACT

BACKGROUND: Poor sleep is common among older adults with mild cognitive impairment (MCI) and may contribute to further cognitive decline. Whether multimodal lifestyle intervention that combines bright light therapy (BLT), physical activity (PA), and good sleep hygiene can improve sleep in older adults with MCI and poor sleep is unknown. OBJECTIVE: To assess the effect of a multimodal lifestyle intervention on sleep in older adults with probable MCI and poor sleep. METHODS: This was a 24-week proof-of-concept randomized trial of 96 community-dwelling older adults aged 65-85 years with probable MCI (<26/30 on the Montreal Cognitive Assessment) and poor sleep (>5 on the Pittsburgh Sleep Quality Index [PSQI]). Participants were allocated to either a multimodal lifestyle intervention (INT); or 2) education + attentional control (CON). INT participants received four once-weekly general sleep hygiene education classes, followed by 20-weeks of: 1) individually-timed BLT; and 2) individually-tailored PA promotion. Our primary outcome was sleep efficiency measured using the MotionWatch8© (MW8). Secondary outcomes were MW8-measured sleep duration, fragmentation index, wake-after-sleep-onset, latency, and PSQI-measured subjective sleep quality. RESULTS: There were no significant between-group differences in MW8 measured sleep efficiency at 24-weeks (estimated mean difference [INT -CON]: 1.18%; 95% CI [-0.99, 3.34]), or any other objective-estimate of sleep. However, INT participants reported significantly better subjective sleep quality at 24-weeks (estimated mean difference: -1.39; 95% CI [-2.72, -0.06]) compared to CON. CONCLUSION: Among individuals with probable MCI and poor sleep, a multimodal lifestyle intervention improves subjective sleep quality, but not objectively estimated sleep.


Subject(s)
Cognition/physiology , Cognitive Dysfunction/psychology , Cognitive Dysfunction/therapy , Healthy Lifestyle/physiology , Sleep Initiation and Maintenance Disorders/psychology , Sleep Initiation and Maintenance Disorders/therapy , Aged , Aged, 80 and over , British Columbia/epidemiology , Circadian Rhythm/physiology , Cognitive Dysfunction/epidemiology , Combined Modality Therapy/methods , Combined Modality Therapy/psychology , Exercise/physiology , Exercise/psychology , Female , Follow-Up Studies , Humans , Life Style , Male , Proof of Concept Study , Single-Blind Method , Sleep Initiation and Maintenance Disorders/epidemiology
12.
J Obstet Gynaecol Can ; 42(2): 150-155, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31843289

ABSTRACT

OBJECTIVE: This study aimed to quantify adverse neonatal outcomes in a cohort of registered midwife (RM)-attended conventional and water births in British Columbia. METHODS: The study included all term singleton births in British Columbia between January 1, 2005 and March 31, 2016 attended by RMs. Births were allocated to a conventional birth cohort or a water birth cohort according to where the actual birth of the neonate took place. The primary outcome was a composite adverse neonatal outcome (Apgar <7 at 5 minutes, resuscitation need, neonatal intensive care unit admission). Secondary outcomes included individual components of the primary outcome, maternal length of labour, and degree of perineal laceration (Canadian Task Force Classification Level II-2). RESULTS: The population included 25 798 births. Of these, 23 201 were conventional, and 2567 were water births. The rate of the composite adverse neonatal outcome was not higher in water births compared with conventional births (hospital conventional, 5.0%; hospital water, 4.2%; home conventional, 3.4%; and home water, 2.9%). Rates of individual components of the composite adverse neonatal score were not greater in the water birth cohort. Maternal outcomes included statistically shorter labours in the water birth cohort and no difference between the cohorts in incidence of third- and fourth-degree lacerations. CONCLUSION: Water births attended by RMs in British Columbia are not associated with higher rates of adverse neonatal outcomes than conventional births attended by midwives.


Subject(s)
Natural Childbirth , Puerperal Disorders/epidemiology , Adult , British Columbia/epidemiology , Cohort Studies , Female , Humans , Infant, Newborn , Infant, Newborn, Diseases/epidemiology , Infant, Newborn, Diseases/etiology , Male , Midwifery , Perinatal Care , Pregnancy , Pregnancy Outcome , Puerperal Disorders/etiology , Registries
13.
BMJ Open ; 8(10): e022220, 2018 10 03.
Article in English | MEDLINE | ID: mdl-30282682

ABSTRACT

OBJECTIVE: Our aim was to investigate if antenatal midwifery care was associated with lower odds of small-for-gestational-age (SGA) birth, preterm birth (PTB) or low birth weight (LBW) compared with general practitioner (GP) or obstetrician (OB) models of care for women of low socioeconomic position. SETTING: This population-level, retrospective cohort study used province-wide maternity, medical billing and demographic data from British Columbia, Canada. PARTICIPANTS: Our study included 57 872 pregnant women, with low socioeconomic position, who: were residents of British Columbia, Canada, carried a singleton fetus, had low to moderate medical/obstetric risk, delivered between 2005 and 2012 and received medical insurance premium assistance. PRIMARY AND SECONDARY OUTCOME MEASURES: We report rates, adjusted ORs (aOR), and 95% CIs for the primary outcome, SGA birth (

Subject(s)
Infant, Small for Gestational Age , Midwifery , Pregnancy Outcome/epidemiology , Premature Birth/epidemiology , Prenatal Care/methods , Socioeconomic Factors , Adolescent , Adult , British Columbia/epidemiology , Female , Gestational Age , Humans , Infant, Low Birth Weight , Infant, Newborn , Logistic Models , Pregnancy , Pregnancy Complications/epidemiology , Prevalence , Retrospective Studies , Risk Factors , Young Adult
14.
Addiction ; 113(12): 2250-2258, 2018 12.
Article in English | MEDLINE | ID: mdl-30238568

ABSTRACT

BACKGROUND AND AIMS: Cannabis use is common among people on opioid agonist treatment (OAT), causing concern for some care providers. However, there is limited and conflicting evidence on the impact of cannabis use on OAT outcomes. Given the critical role of retention in OAT in reducing opioid-related morbidity and mortality, we aimed to estimate the association of at least daily cannabis use on the likelihood of retention in treatment among people initiating OAT. As a secondary aim we tested the impacts of less frequent cannabis use. DESIGN: Data were drawn from two community-recruited prospective cohorts of people who use illicit drugs (PWUD). Participants were followed for a median of 81 months (interquartile range = 37-130). SETTING: Vancouver, Canada. PARTICIPANTS: This study comprised a total of 820 PWUD (57.8% men, 59.4% of Caucasian ethnicity, 32.2% HIV-positive) initiating OAT between December 1996 and May 2016. The proportion of women was higher among HIV-negative participants, with no other significant differences. MEASUREMENTS: The primary outcome was retention in OAT, defined as remaining in OAT (methadone or buprenorphine/naloxone-based) for two consecutive 6-month follow-up periods. The primary explanatory variable was cannabis use (at least daily versus less than daily) during the same 6-month period. Confounders assessed included: socio-demographic characteristics, substance use patterns and social-structural exposures. FINDINGS: In adjusted analysis, at least daily cannabis use was positively associated with retention in OAT [adjusted odds ratio (aOR) = 1.21, 95% confidence interval (CI) = 1.04-1.41]. Our secondary analysis showed that compared with non-cannabis users, at least daily users had increased odds of retention in OAT (aOR = 1.20, 95% CI = 1.02-1.43), but not less than daily users (aOR = 1.00, 95% CI = 0.87-1.14). CONCLUSIONS: Among people who use illicit drugs initiating opioid agonist treatment in Vancouver, at least daily cannabis use was associated with approximately 21% greater odds of retention in treatment compared with less than daily consumption.


Subject(s)
Marijuana Use/epidemiology , Opiate Substitution Treatment/statistics & numerical data , Opioid-Related Disorders/drug therapy , Retention in Care/statistics & numerical data , Adult , Analgesics, Opioid/therapeutic use , British Columbia/epidemiology , Buprenorphine, Naloxone Drug Combination/therapeutic use , Female , Humans , Longitudinal Studies , Male , Methadone/therapeutic use , Middle Aged , Opioid-Related Disorders/epidemiology
15.
AIDS Behav ; 22(5): 1530-1540, 2018 05.
Article in English | MEDLINE | ID: mdl-28612214

ABSTRACT

Using data from the Comparison of Outcomes and Service Utilization Trends (COAST) study we examined factors associated with mood disorder diagnosis (MDD) among people living with HIV (PLHIV) and HIV-negative individuals in British Columbia, Canada. MDD cases were identified between 1998 and 2012 using International Classification of Disease 9 and 10 codes. A total of 491,796 individuals were included and 1552 (23.7%) and 60,097 (12.4%) cases of MDD were identified among the HIV-positive and HIV-negative populations, respectively. Results showed HIV status was associated with greater odds of MDD among men and lower odds among women. Among PLHIV, MDD was significantly associated with: identifying as gay, bisexual or other men who have sex with men compared to heterosexuals; higher viral load; history of injection drug use; and concurrent anxiety, dysthymia, and substance use disorders. Findings highlight the need for comprehensive and holistic HIV and mental health care.


Subject(s)
HIV Seronegativity , HIV Seropositivity/epidemiology , Mood Disorders/diagnosis , Substance Abuse, Intravenous/epidemiology , Substance-Related Disorders/epidemiology , Adult , Anxiety Disorders , Bisexuality/psychology , Bisexuality/statistics & numerical data , British Columbia/epidemiology , Cohort Studies , Female , Heterosexuality/psychology , Heterosexuality/statistics & numerical data , Homosexuality, Male/psychology , Homosexuality, Male/statistics & numerical data , Humans , Male , Middle Aged , Mood Disorders/epidemiology , Substance Abuse, Intravenous/complications , Substance-Related Disorders/complications , Viral Load
16.
BMC Infect Dis ; 17(1): 604, 2017 09 04.
Article in English | MEDLINE | ID: mdl-28870175

ABSTRACT

BACKGROUND: Every year, over 1 million people develop isoniazid (INH) resistant tuberculosis (TB). Yet, the optimal treatment regimen remains unclear. Given increasing prevalence, the clinical efficacy of regimens used by physicians is of interest. This study aims to examine treatment outcomes of INH resistant TB patients, treated under programmatic conditions in British Columbia, Canada. METHODS: Medical charts were retrospectively reviewed for cases of culture-confirmed INH mono-resistant TB reported to the BC Centre for Disease Control (BCCDC) from 2002 to 2014. Treatment regimens, patient and strain characteristics, and clinical outcomes were analysed. RESULTS: One hundred sixty five cases of INH mono-resistant TB were included in analysis and over 30 different treatment regimens were prescribed. Median treatment duration was 10.5 months (IQR 9-12 months) and treatment was extended beyond 12 months for 26 patients (15.8%). Fifty six patients (22.6%) experienced an adverse event that resulted in a drug regimen modification. Overall, 140 patients (84.8%) had a successful treatment outcome while 12 (7.2%) had an unsuccessful treatment outcome of failure (n = 2; 1.2%), relapse (n = 4; 2.4%) or all cause mortality (n = 6; 3.6%). CONCLUSION: Our treatment outcomes, while consistent with findings reported from other studies in high resource settings, raise concerns about current recommendations for INH resistant TB treatment. Only a small proportion of patients completed the recommended treatment regimens. High quality studies to confirm the effectiveness of standardized regimens are urgently needed, with special consideration given to trials utilizing fluoroquinolones.


Subject(s)
Antitubercular Agents/therapeutic use , Drug Resistance, Bacterial/drug effects , Isoniazid/therapeutic use , Tuberculosis/drug therapy , Adult , British Columbia/epidemiology , Female , Fluoroquinolones/therapeutic use , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Mycobacterium tuberculosis/drug effects , Recurrence , Retrospective Studies , Treatment Outcome , Tuberculosis/epidemiology , Tuberculosis/microbiology
17.
Harm Reduct J ; 13(1): 31, 2016 11 22.
Article in English | MEDLINE | ID: mdl-27876048

ABSTRACT

BACKGROUND: People living with HIV (PLHIV) who are also marginalized by social and structural inequities often face barriers to accessing and adhering to HIV treatment and care. The Dr. Peter Centre (DPC) is a non-profit integrated care facility with a supervised injection room that serves PLHIV experiencing multiple barriers to social and health services in Vancouver, Canada. This study examines whether the DPC is successful in drawing in PLHIV with complex health issues, including addiction. METHODS: Using data collected by the Longitudinal Investigations into Supportive and Ancillary health services (LISA) study from July 2007 to January 2010, linked with clinical variables available through the British Columbia Centre for Excellence in HIV/AIDS Drug Treatment Program, we identified DPC and non-DPC clients with a history of injection drug use. Bivariable and multivariable logistic regression analyses compared socio-demographic and clinical characteristics of DPC clients (n = 76) and non-DPC clients (n = 482) with a history of injection drug use. RESULTS: Of the 917 LISA participants included within this analysis, 100 (10.9%) reported being a DPC client, of which 76 reported a history of injection drug use. Adjusted results found that compared to non-DPC clients with a history of injection drug use, DPC-clients were more likely to be male (AOR: 4.18, 95% CI = 2.09-8.37); use supportive services daily vs. less than daily (AOR: 3.16, 95% CI = 1.79-5.61); to have been diagnosed with a mental health disorder (AOR: 2.11; 95% CI: 1.12-3.99); to have a history of interpersonal violence (AOR: 2.76; 95% CI: 1.23-6.19); and to have ever experienced ART interruption longer than 1 year (AOR: 2.39; 95% CI: 1.38-4.15). CONCLUSIONS: Our analyses suggest that the DPC operating care model engages PLHIV with complex care needs, highlighting that integrated care facilities are needed to support the multiple intersecting vulnerabilities faced by PLHIV with a history of injection drug use living within urban centres in North America and beyond.


Subject(s)
Delivery of Health Care, Integrated/statistics & numerical data , Epidemics , HIV Infections/therapy , Illicit Drugs , Substance Abuse, Intravenous/rehabilitation , British Columbia/epidemiology , Female , HIV Infections/epidemiology , Humans , Longitudinal Studies , Male , Needle-Exchange Programs/statistics & numerical data , Social Support , Substance Abuse Treatment Centers/statistics & numerical data , Urban Health/statistics & numerical data
18.
Cancer Epidemiol ; 45: 119-125, 2016 12.
Article in English | MEDLINE | ID: mdl-27810483

ABSTRACT

BACKGROUND: The risk for epithelial ovarian cancer associated with the consumption of caffeinated beverages (tea, coffee, and soft drinks) and green tea is inconclusive. However, few studies have investigated the type of caffeinated beverage or the type of tea. OBJECTIVE: We assessed consumption of tea (black/caffeinated tea and green tea separately), coffee, and caffeinated soft drinks, as well as level of consumption, and the risk for epithelial ovarian cancer and its histotypes. STUDY DESIGN: This study was conducted within a population-based case-control study in Alberta and British Columbia, Canada from 2001 to 2012. After restricting to cases of epithelial invasive cancers and controls aged 40-79 years who completed an interview that included coffee, soft drink, and tea consumption (ascertained starting in 2005 in British Columbia and 2008 in Alberta), there were a total of 524 cases and 1587 controls. Those that did not meet the threshold for beverage consumption (at least once per month for 6 months or more) were classified as non-drinkers. Adult lifetime cumulative consumption (cup-years=cups/day*years) was calculated. Unconditional logistic regression was used to estimate adjusted odds ratios (aOR) and 95% confidence intervals (CI) to describe the association between the relevant drink consumption and risk. RESULTS: No excess risk was seen for coffee or caffeinated soft drinks. Similarly, any tea consumption was not associated with risk, but when stratified by the type of tea, there was an increase in risk in black tea only drinkers (aOR=1.56; 95% CI:1.07-2.28 for >40 cup-years), but no excess risk for the exclusive green tea drinkers. Similar findings were observed for post-menopausal women. The association for black tea only consumption was mainly seen in the endometrioid histotype (aOR=3.19; 95% CI: 1.32-7.69). CONCLUSION: Black tea consumption may be associated with an increased risk epithelial ovarian carcinoma. The excess risk is seen only in the endometrioid histotype but not in serous or clear cell. Further studies are required to confirm these findings and identify the constituents in black tea that may increase the risk.


Subject(s)
Beverages/adverse effects , Caffeine/adverse effects , Coffee/adverse effects , Neoplasms, Glandular and Epithelial/etiology , Ovarian Neoplasms/etiology , Tea/adverse effects , Adult , Aged , British Columbia/epidemiology , Carcinoma, Ovarian Epithelial , Case-Control Studies , Female , Humans , Middle Aged , Neoplasms, Glandular and Epithelial/epidemiology , Odds Ratio , Ovarian Neoplasms/epidemiology , Risk Factors , Young Adult
19.
CMAJ ; 188(17-18): E456-E465, 2016 Dec 06.
Article in English | MEDLINE | ID: mdl-27672220

ABSTRACT

BACKGROUND: Most studies examining geographic barriers to maternity care in industrialized countries have focused solely on fetal and neonatal outcomes. We examined the association between rural residence and severe maternal morbidity, in addition to perinatal mortality and morbidity. METHODS: We conducted a retrospective population-based cohort study of all women who gave birth in British Columbia, Canada, between Jan. 1, 2005, and Dec. 31, 2010. We compared maternal mortality and severe morbidity (e.g., eclampsia) and adverse perinatal outcomes (e.g., perinatal death) between women residing in areas with moderate to no metropolitan influence (rural) and those living in metropolitan areas or areas with a strong metropolitan influence (urban). We used logistic regression analysis to obtain adjusted odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: We found a significant association between death or severe maternal morbidity and rural residence (adjusted OR 1.15, 95% CI 1.03-1.28). In particular, women in rural areas had significantly higher rates of eclampsia (adjusted OR 2.70, 95% CI 1.79-4.08), obstetric embolism (adjusted OR 2.16, 95% CI 1.14-4.07) and uterine rupture or dehiscence (adjusted OR 1.96, 95% CI 1.42-2.72) than women in urban areas. Perinatal mortality did not differ significantly between the study groups. Infants in rural areas were more likely than those in urban areas to have a severe neonatal morbidity (adjusted OR 1.14, 95% CI 1.02-1.29), to be born preterm (adjusted OR 1.06, 95% CI 1.01-1.11), to have an Apgar score of less than 7 at 5 minutes (adjusted OR 1.24, 95% CI 1.13-1.31) and to be large for gestational age (adjusted OR 1.14, 95% CI 1.10-1.19). They were less likely to be small for gestational age (adjusted OR 0.90, 95% CI 0.85-0.95) and to be admitted to an neonatal intensive care unit (NICU) (adjusted OR 0.36, 95% CI 0.33-0.38) compared with infants in urban areas. INTERPRETATION: Compared with women in urban areas, those in rural areas had higher rates of severe maternal morbidity and severe neonatal morbidity, and a lower rate of NICU admission. Maternity care providers in rural regions need to be aware of potentially life-threatening maternal and perinatal complications requiring advanced obstetric and neonatal care.


Subject(s)
Fetal Macrosomia/epidemiology , Maternal Mortality , Perinatal Mortality , Pregnancy Complications/epidemiology , Premature Birth/epidemiology , Rural Population/statistics & numerical data , Urban Population/statistics & numerical data , Adolescent , Adult , Apgar Score , British Columbia/epidemiology , Cohort Studies , Eclampsia/epidemiology , Embolism/epidemiology , Female , Home Childbirth/statistics & numerical data , Humans , Infant, Newborn , Infant, Small for Gestational Age , Logistic Models , Midwifery/statistics & numerical data , Obstetrics/statistics & numerical data , Odds Ratio , Physicians, Family/statistics & numerical data , Pregnancy , Retrospective Studies , Uterine Rupture/epidemiology , Young Adult
20.
Nutrients ; 8(9)2016 Sep 01.
Article in English | MEDLINE | ID: mdl-27598193

ABSTRACT

Low periconceptional vitamin B6 (B6) status has been associated with an increased risk of preterm birth and early pregnancy loss. Given many pregnancies are unplanned; it is important for women to maintain an adequate B6 status throughout reproductive years. There is limited data on B6 status in Canadian women. This study aimed to assess the prevalence of B6 deficiency and predictors of B6 status in young adult women in Metro Vancouver. We included a convenience sample of young adult non-pregnant women (19-35 years; n = 202). Vitamin B6 status was determined using fasting plasma concentrations of pyridoxal 5'-phosphate (PLP). Mean (95% confidence interval) plasma PLP concentration was 61.0 (55.2, 67.3) nmol/L. The prevalence of B6 deficiency (plasma PLP < 20 nmol/L) was 1.5% and that of suboptimal B6 status (plasma PLP = 20-30 nmol/L) was 10.9%. Body mass index, South Asian ethnicity, relative dietary B6 intake, and the use of supplemental B6 were significant predictors of plasma PLP. The combined 12.4% prevalence of B6 deficiency and suboptimal status was lower than data reported in US populations and might be due to the high socioeconomic status of our sample. More research is warranted to determine B6 status in the general Canadian population.


Subject(s)
Pyridoxal Phosphate/blood , Urban Health , Vitamin B 6 Deficiency/epidemiology , Women's Health , Adult , Age Factors , Biomarkers/blood , British Columbia/epidemiology , Cross-Sectional Studies , Female , Health Status , Health Surveys , Humans , Linear Models , Multivariate Analysis , Prevalence , Risk Factors , Sex Factors , Vitamin B 6 Deficiency/blood , Vitamin B 6 Deficiency/diagnosis , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL